mvmlifesciences.com
MVM Life Science Partners LLP : News
http://www.mvmlifesciences.com/news/2015/jul/23/cara-therapeutics-announces-positive-results-from-phase-ii-trial
Cara Therapeutics Announces Positive Results from Phase II Trial. Cara Therapeutics Announces Positive Results from Phase II Trial. Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to selectively target peripheral kappa opioid receptors, has announced statistically significant topline results from its Phase II trial of its lead kappa opioid agonist, CR845, for the treatment of moderate to severe uremic pruritus (UP).
mvmlifescience.com
MVM Life Science Partners LLP : News
http://www.mvmlifescience.com/news/2015/jul/23/cara-therapeutics-announces-positive-results-from-phase-ii-trial
Cara Therapeutics Announces Positive Results from Phase II Trial. Cara Therapeutics Announces Positive Results from Phase II Trial. Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to selectively target peripheral kappa opioid receptors, has announced statistically significant topline results from its Phase II trial of its lead kappa opioid agonist, CR845, for the treatment of moderate to severe uremic pruritus (UP).
edscapitalgroup.com
Cannabis Companies – EDS Capital Group Corporation
http://edscapitalgroup.com/cannabis-companies
Current Acquisitions & Negotiations. We have compiled a page with listings of the current publicly traded cannabis companies. We will update the list in order to keep our clients and partners up-to-date with the most recent additions. EDS currently holds substantial shares in the companies highlighted with an *. Vapor Hub Int ernational Inc. Green Cures and Botanical Distribution Inc. Creative Edge Nutrition Inc. Totally Hemp Crazy Inc. Mountain High Acquisitions Corp. American Cannabis Company Inc.
marijuanastocks.com
List of Marijuana Stocks - Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™
http://marijuanastocks.com/content/list-marijuana-stocks
List of Marijuana Stocks. Trends & Articles. Monday, August 29, 2016. Welcome to Marijuana Stocks. List of Marijuana Stocks. Why California’s Proposition 64 Could help Marijuana Reform. Sponsor of Anti-Cannabis Measure Retracts Montana Ballot Efforts. Michigan’s Recreational Marijuana Initiative Might Be Over Sooner Than Later. Israel’s Silent Work on Marijuana Research is Starting to Make Noise. Could This be the End of Mississippi’s Medical Marijuana Research Program. Trends & Articles. DEA is a Patsy ...
dallamagna.com
Dal LaMagna Biography | Dal Lamagna
http://dallamagna.com/dal-lamagna-biography
Dal in the News. Dal LaMagna started Tweezerman. In 1980 and built it into a multi-national, premier personal-care-tool brand that practices responsible capitalism and corporate social responsibility. Part of the companys mission is to benefit all. Stakeholders: including financial partners, employees, customers, vendors, the community and the natural environment. Today, Dal is the CEO and President of IceStone. A company that makes counter tops out of recycled glass and cement in Brooklyn, New York.
axxiem.com
Axxiem Web Solutions - Axxiem Portfolio Gallery
http://www.axxiem.com/project.php?id=12&page=id=12&page=4
Corporate Office / Sales. Legal, Financial, Consulting. Portfolio - Recent Projects. Legal, Financial, Consulting. Lsaquo;‹ prev. Next ››. Dr Marc D. Danziger is an experienced, board certified urologist and a leading practitioner of Robotic Protastectomy. The objective of the project was to communicate Dr. Danziger's role as a leader in the field of Robotic Protastectomy, while also speaking to his larger experience as a practicing urologist in New York. Most importantly, the new Cygnus website features...
mvmlifescience.co.uk
MVM Life Science Partners LLP : News
http://mvmlifescience.co.uk/news/2015/jul/23/cara-therapeutics-announces-positive-results-from-phase-ii-trial
Cara Therapeutics Announces Positive Results from Phase II Trial. Cara Therapeutics Announces Positive Results from Phase II Trial. Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to selectively target peripheral kappa opioid receptors, has announced statistically significant topline results from its Phase II trial of its lead kappa opioid agonist, CR845, for the treatment of moderate to severe uremic pruritus (UP).
sinatrapain.wordpress.com
Professional CV | Sinatra Analgesic Consultants
https://sinatrapain.wordpress.com/professional-cv
Expert Pain Management Consultation. Skip to primary content. About Dr. Sinatra. Critical Issues in Acute Pain Management. RAYMOND S. SINATRA, M.D., Ph.D. Director, Sinatra Analgesic Consultants. Emertius Professor of Anesthesiology and Pain Management. Yale University School of Medicine. BS Adelphi University 1970. PhD (Neuroscience), S.U.N.Y. Downstate Medical Center, School of Graduate Studies, Brooklyn, NY 1978. MD SUN.Y. Downstate Medical Center College of Medicine, Brooklyn, NY, 1982. 1985 – ...
dpbioventures.com
Devon Park Bioventures - Active Portfolio Companies
http://www.dpbioventures.com/portfolio/index.htm
Is a biotechnology company focused on developing novel therapeutics to treat pain and inflammation. The lead product is a kappa opioid receptor agonist that provides potent analgesia without CNS side effects. Specializes in the development of inhaled antibiotics to treat serious hospital-acquired respiratory infections. The lead product is a combination antibiotic for the treatment of ventilator-associated pneumonia. Discovers and develops novel antibiotics to combat drug resistant bacterial infections&#...